Ecromeximab
Based on 1 Customer Validation
Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells.
For research use only. We do not sell to patients.
- Purity: 99.70%
- CAS No.: 292819-64-8
- Molecular Weight:145.26 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG1 kappa
Human
ganglioside GD3
100049518 [NCBI]
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG1 kappa
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 292819-64-8
-
Appearance Liquid
-
Molecular Weight 145.26 kDa
-
Color Colorless to light yellow
-
SMILES
[Ecromeximab]
-
Synonyms
KM 871; KW 2871
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (253 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Ecromeximab. IMGT.
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)